ArticleJournal of molecular modeling2026
Insights into the mechanism, selectivity, solvent, and temperature effect in the Diels-Alder reactions of 2,5-bis(hydroxymethyl)furan and maleimides derivatives leading to anticancer norcantharimide derivatives: an MEDT study.
Article in Journal of molecular modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextThe [4 + 2] cycloaddition involving 2,5-bis(hydroxymethyl)furan (BHMF) and N-substituted maleimides constitutes an efficient synthetic strategy for accessing norcantharimide derivatives, which are of considerable interest due to their diverse pharmacological properties. Understanding the electronic and mechanistic determinants governing this transformation is essential for controlling the competition between en- and ex-stereoselective approaches and reactivity. In this study, the cycloaddition process was investigated from a molecular perspective to elucidate the nature of the interactions driving the reaction. The results indicate that the transformation proceeds via a polar, yet electronically asynchronous mechanism, characterized by a donor-acceptor interaction between the electron-rich BHMF and electron-deficient maleimides. The computed energy profiles reveal a preference between en- and ex-stereoselective approaches, while electron density analyses confirm a forward charge transfer from the diene to the dienophile. Furthermore, noncovalent interactions contribute significantly to transition-state stabilization, providing a rational basis for the observed selectivity and energetic trends.
methodsAll calculations were performed within the framework of density functional theory (DFT). The geometries of all stationary points, including reactants, transition states, and cycloadducts, were fully optimized at the ωB97XD/6-311++G(d,p) level of theory. Frequency calculations were carried out at the same level to confirm the nature of the stationary points and to obtain thermochemical corrections. Conceptual DFT descriptors were derived to evaluate global reactivity indices and to characterize the electrophilic and nucleophilic behavior of the reacting species. Topological analysis of the electron density was conducted to gain insight into bonding patterns and charge distribution. The global electron density transfer (GEDT) was calculated at the transition states to quantify the polar character of the reaction. In addition, noncovalent interactions were analyzed using the independent gradient model (IGM), allowing visualization and quantification of weak intermolecular interactions governing transition-state stabilization. All computational analyses were carried out using standard quantum chemical software packages.
Indexed as
Identifiers
42203971What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.